Eastgate Biotech Corp. (ETBI)

OTCMKTS · Delayed Price · Currency is USD
0.0010
0.00 (0.00%)
At close: Mar 13, 2026
Market Cap1.06M -74.4%
Revenue (ttm)137.64K +45,325.1%
Net Income-3.82M
EPS-0.01
Shares Out1.06B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume42,000
Average Volume1,395,290
Open0.0010
Previous Closen/a
Day's Range0.0010 - 0.0010
52-Week Range0.0000 - 0.0045
Beta-3,995.34
RSI49.58
Earnings Daten/a

About Eastgate Biotech

Eastgate Biotech Corp., a development stage company, develops novel formulations of natural compounds and pharmaceutical products. The company is developing pharmaceutical products, such as Lorazepam oral spray for acute seizures emergency treatment; Ketoconazole 2% topical ointment for treatment of skin fungal infections; and Metformin chewable/ sublingual tablets for treatment of type 2 diabetes. It is also developing natural products and dietary supplements, including E-drops Nano and PURALEN that are self-nanoemulsifying compositions contai... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1999
Employees 3
Stock Exchange OTCMKTS
Ticker Symbol ETBI
Full Company Profile

Financial Performance

Financial Statements